Coronavirus vaccine COVAXIN update: Human trial process starts at Hyderabad's NIMS
Hyderabad’s Nizam’s Institute of Medical Sciences was one of the trial sites that received the ICMR’s letter
Last week, the drug regulator recently granted permission to initiate Phase I & II human clinical trials for COVID-19 Vaccine Covaxin
The much-awaited trial process of India's first possible vaccine against COVID-19, Covaxin, has started on Tuesday at the Nizam's Institute of Medical Sciences (NIMS), a top official confirmed. Developed by Bharat Biotech, the Covaxin will be tested on over 1,100 people in two phases. The company had a plan to enroll 375 participants to test COVID-19 vaccine candidate this month.